Legend Biotech (LEGN) Inventory (2019 - 2025)

Legend Biotech has reported Inventory for 7 years, with the latest figure at $32.0 million in Q4 2025.

• For the quarter ending Q4 2025, Inventory rose 33.89% year-over-year to $32.0 million; the trailing twelve-month figure through Dec 2025 stood at $32.0 million (up 33.89% YoY), and the FY2025 full-year result was $32.0 million, up 33.89% from the prior year.
• Inventory for Q4 2025 stood at $32.0 million, up from $29.2 million in the prior quarter.
• The five-year high for Inventory was $35.6 million in Q2 2025, with the low at $1700.0 in Q2 2021.
• Historically, Inventory has averaged $16.5 million across 5 years, with a median of $18.4 million in 2023.
• Annual changes were most pronounced in 2021 — Inventory retreated 2.83% — and 2022, when it jumped 137954.36%.
• Legend Biotech's Inventory stood at $1.7 million in 2021, then surged by 492.0% to $10.4 million in 2022, then jumped by 87.69% to $19.4 million in 2023, then advanced by 22.99% to $23.9 million in 2024, then jumped by 33.89% to $32.0 million in 2025.
• The last three Inventory figures came in at $32.0 million (Q4 2025), $29.2 million (Q3 2025), and $35.6 million (Q2 2025), per Business Quant data.